Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,821,220
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
4,852,401
-
Shares change
-
-14,760
-
Total reported value, excl. options
-
$66,866,000
-
Value change
-
-$203,431
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$13.78
Significant Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q2 2021
10 filings reported holding NBTX - Nanobiotix S.A. - Common Stock as of Q2 2021.
Nanobiotix S.A. - Common Stock (NBTX) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,852,401 shares
of 46,821,220 outstanding shares and own 10.36% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (1,400,000 shares), PERCEPTIVE ADVISORS LLC (1,059,800 shares), Artal Group S.A. (1,000,000 shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (750,000 shares), ORBIMED ADVISORS LLC (500,000 shares), Woodline Partners LP (59,994 shares), UBS Group AG (59,791 shares), MILLENNIUM MANAGEMENT LLC (22,233 shares), MORGAN STANLEY (300 shares), and Activest Wealth Management (283 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.